Skip to main content

COMMUNITY HEALTH SYSTEMS INC

For the period ended Dec 31, 2023. Filed Feb 21, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 21, 2024

CYH$2.26+2.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 16. Form 10-K Summary

None.

SIGNAT URES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Community Health Systems, Inc.
By:/s/ Tim L. Hingtgen
Tim L. Hingtgen
Director andChief Executive Officer
Date:February 21, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

NameTitleDate
/s/ Tim L. HingtgenDirector andFebruary 21, 2024
Tim L. HingtgenChief Executive Officer
/s/ Kevin J. HammonsPresident andFebruary 21, 2024
Kevin J. HammonsChief Financial Officer
/s/ Jason K. JohnsonSenior Vice President andFebruary 21, 2024
Jason K. JohnsonChief Accounting Officer
/s/ Wayne T. SmithChairman of theFebruary 21, 2024
Wayne T. SmithBoard of Directors
/s/ Susan W. BrooksDirectorFebruary 21, 2024
Susan W. Brooks
/s/ Ronald L. Burgess, Jr.DirectorFebruary 21, 2024
Ronald L. Burgess, Jr.
/s/ John A. ClericoDirectorFebruary 21, 2024
John A. Clerico
/s/ Michael DinkinsDirectorFebruary 21, 2024
Michael Dinkins
/s/ James S. Ely IIIDirectorFebruary 21, 2024
James S. Ely III
/s/ John A. FryDirectorFebruary 21, 2024
John A. Fry
/s/ Joseph A. Hastings, D.M.DDirectorFebruary 21, 2024
Joseph A. Hastings, D.M.D
/s/ Elizabeth T. HirschDirectorFebruary 21, 2024
Elizabeth T. Hirsch
/s/ William Norris Jennings, M.D.DirectorFebruary 21, 2024
William Norris Jennings, M.D.
/s/ K. Ranga Krishnan, MBBSDirectorFebruary 21, 2024
K. Ranga Krishnan, MBBS
/s/ H. James Williams, Ph.D.DirectorFebruary 21, 2024
H. James Williams, Ph.D.
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.